Ab Interno Canaloplasty (ABiC™) In The Spotlight

Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.

How Does Canaloplasty Compare to Other Glaucoma Treatments?

How does Canaloplasty compare to other glaucoma treatments in terms of IOP Lowering benefits and average medication?  Here’s a summary from Dr. Douglas J. Rhee’s talk given on April 13, 2018 during the ASCRS 2018 Glaucoma Day “Is Trabeculectomy...

Ab-Interno Canaloplasty: Two-Year Results

[Photo Credit: www.augencentrumkoeln.de] Not everyone with glaucoma is excited about having an implant (however small) permanently placed in the eye. Additionally, not everyone with glaucoma has a cataract. Unfortunately, all current FDA approved minimally invasive...

Comparison to Canaloplasty without the Stegmann Canal Expander®

When the results of this study are compared to the results of prior long-term studies of Canaloplasty glaucoma surgery, use of the Stegmann Canal Expander® appears to provide an additional 3mmHg of IOP lowering effect.2 Source: Canal Expander | Canal Expander...

Risks of Canaloplasty with the Stegmann Canal Expander®

The risks of canaloplasty with the Stegmann Canal Expander® were shown to be quite similar to Canaloplasty without the Stegmann Canal Expander®. Just over one quarter of patients experienced a hyphema (blood in the front part of the eye). However, this is viewed by...

Pin It on Pinterest